Project Grant HT94252510278
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...
Albert Einstein College of Medicine (AECOM) was awarded a $672,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on Treatment-Induced Metastasis in Ewing Sarcoma. The two-year grant runs from June 1, 2023 to May 31, 2025 and will support AECOM's investigation into medical solutions for metastatic cancers affecting service members, in line with the program's goals of transforming military...
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
The U.S. Defense Health Agency awarded a $488,198 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation to support the development and evaluation of agents for a poor prognostic vertebrate model of Ewing sarcoma. The grant term runs from September 1, 2024 to August 31, 2027. As a sub-award under this grant, Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of...
The Department of the Army Medical Command awarded a $544,250 Project Grant to the University of Washington under the Military Medical Research and Development program (CFDA 12.420) to identify epigenetic-based targets against cancer stem cells in rhabdomyosarcoma. The three-year award beginning August 1, 2022 will support research to investigate medical solutions for battlefield injuries by exploring innovative biomedical research approaches. Specifically, the University of Washington will...
The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This federal Project Grant award of $808,141, issued by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research targeting inflammatory pathways in breast cancer brain metastases. The award provides funding to Weill Medical College of Cornell University, a leading academic medical institution, to conduct research on using anti-VEGF ultrasmall particle therapy for the treatment of edema and radiation necrosis. The...
The Department of the Army Medical Command awarded a $537,120 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program. The grant will support targeted combination therapy research in a novel in vivo model of fibrolamellar carcinoma from August 1, 2022 to July 31, 2024. The Military Medical Research and Development program aims to advance biomedical research that transforms military and public health care. This award will fund the...
The Department of the Army Medical Command awarded a $1,520,818 Project Grant to Southern Research Institute under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2025 to develop rank signaling inhibitors for treating breast cancer bone metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...